Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study

J Am Acad Dermatol. 2014 Jun;70(6):1146-9. doi: 10.1016/j.jaad.2014.03.005.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adalimumab
  • Adult
  • Age Distribution
  • Alopecia Areata / chemically induced*
  • Alopecia Areata / epidemiology*
  • Alopecia Areata / physiopathology
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • France / epidemiology
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Assessment
  • Sex Distribution
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab